Navigation Links
Miami’s Preferred Cord Blood Laboratory, GeneCell International, Partakes in North Shore Medical Center and Hialeah Hospital’s OB/GYN Symposium
Date:9/20/2013

Miami, Florida (PRWEB) September 20, 2013

The OB/GYN Symposium will be focused on the areas of cancer and genetic screening, management of cervical dysplasia, fetal neural protection, and other related topics in the field of OB/GYN. The symposium is set to take place on Saturday, September 21, 2013, from 7 a.m. to 7 p.m. at the Doral Golf Resort & Spa, located at 4400 N.W. 87th Avenue, Miami, FL 33178.

“We believe in offering the best support to the medical community, this will ensure doctors will provide parents with the best and most up-to-date information so they are able to make an informed decision on preserving their child’s stems cells,” said GeneCell’s Physician’s Relation’s Manager, Lisa Reyes Munoz.

GeneCell International specializes in the collection, transport, processing and cryogenic storage of adult stem cells from various sources including; umbilical cord blood, cord tissue segment (known as Wharton’s Jelly), dental pulp (teeth) and adipose tissue (fat) that can later be used to treat a variety of diseases. The laboratory is also involved in scientific research and development with a range of stem cells from various adult tissues. The facility is governed and inspected by the FDA, Florida Department of Health and several other regulating bodies to ensure the safety of these cellular therapies.

“For me, the opportunity for meeting and discussing the scientific aspect of these life-saving cells with the physicians is rewarding," added GeneCell’s Laboratory Manager, Priscilla Pages.

Cord blood is rich in stem cells and there are fewer risks for the recipient’s immune system to reject the cells, because certain immune cells found in the cord blood are not mature. Cord blood can be used to treat the child from whom the blood was collected as well as some first-degree relatives who are a close genetic match, such as family members. Additionally, patients can get the treatment in about three weeks - as opposed to six to eight for bone marrow from an adult donor.

“Informing all attending physicians on the importance of cord blood banking and the differences between these non-controversial cells is imperative,” added GeneCell’s Director of Operations, Jose Cirino

GeneCell International presently conducts monthly cord blood workshops at its Miami, West Kendall, facility in order to further educate and update the community on the advancements of stem cells, both hematopoietic (cord) and mesenchymal (cord tissue, dental and adipose).

Umbilical cord blood preservation is a process by which blood is collected from the umbilical cord of a newborn baby and is stored cryogenically in a specially-designated bank. According to the National Marrow Donor Program, cord blood contains cells that can be transfused to a patient to treat various diseases, including lymphoma and leukemia. Currently, there are approximately 80 diseases and the list of illnesses utilizing cord blood stem cells, as a treatment, continues to grow.

GeneCell International, LLC is a trusted provider in the collection, processing and storage of adult stem cells from various sources which have the potential to treat a variety of diseases and disorders. Headquartered in Miami, Florida and a local office in Central Florida and international offices or laboratories in Colombia, Costa Rica, Dominican Republic, Honduras, India, Peru, Puerto Rico, and Venezuela, GeneCell operates state of the art laboratories and storage facilities for the cord blood and dental pulp of thousands of clients. For more information and to learn more about cord blood banking, dental pulp or other GeneCell services, please visit our website at http://www.GeneCell.com.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11143568.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. GeneCell International, Miami’s Preferred Cord Blood Laboratory, is Pleased to Announce That July is National Cord Blood Awareness Month
2. CellerateRX® Added to List of Preferred Products for Golden Living Healthcare Network
3. BioMed Realty Trust Declares Fourth Quarter 2011 Common Stock and Preferred Stock Dividends
4. Cell Therapeutics Announces Institutional Investor to Purchase $40 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock
5. BioMed Realty Trust Declares Second Quarter 2012 Common Stock And Preferred Stock Dividends
6. Ekahau - A Preferred Provider of Real-Time Location Solutions - Is Awarded an Agreement with the Premier Healthcare Alliance
7. University of Colorado Cancer Center Study Shows the Preferred Feeding Method is not the Medically Best in Malnourished Pediatric Cancer Patients
8. Despite Lucentiss Recent Expanded Label for Diabetic Macular Edema, Avastin Remains the Preferred Intravitreal Therapy for Diabetic Macular Edema in the United States
9. FindTheBest Helps Parents Find Cord Blood Banks
10. Cord Blood America Announces DTCC Removes "Chill" Imposed in December 2010
11. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... Jan. 18, 2017   Boston Biomedical , an ... to target cancer stemness pathways, will feature data from ... at the 2017 ASCO Gastrointestinal Cancers Symposium, held from ... Napabucasin is an orally-administered investigational agent ... i Cancer stem cells (CSCs) possess the property ...
(Date:1/18/2017)... ... 2017 , ... Whitehouse Labs has furthered its efforts towards ... (AMRI), the scientific staff dedicated to Extractables / Leachables & Impurities has more ... 2017. Extractable & Leachable evaluations have become increasingly more vital to successful product ...
(Date:1/18/2017)... ... January 18, 2017 , ... BidMed, LLC, announced it ... and genetic testing lab equipment from two different leading institutes. This highly specialized laboratory ... of the United States. This 1-day online auction will take place on BidMed’s ...
(Date:1/18/2017)...  Caris Life Sciences, a leading innovator in ... private funder of pancreatic cancer research, are collaborating ... of immunotherapy in the treatment of pancreatic cancer. ... identify potential trial candidates based on biomarker expression ... study investigators. The Lustgarten Foundation is a sponsor ...
Breaking Biology Technology:
(Date:1/6/2017)... , Jan. 5, 2017  SomaLogic announced ... "Digital Life Alliance" established by iCarbonX, the ... to build a "Global Digital Health Ecosystem that ... a combination of individual,s biological, behavioral and psychological ... agreement between the companies, SomaLogic will provide proteomics ...
(Date:1/3/2017)... LAS VEGAS , Jan. 3, 2017 ... announced the introduction of Onitor Track, an innovative biometric ... and men, showcasing this month at the 2017 Consumer ... . In the U.S., the World ... affect more than two-thirds of adults who are overweight ...
(Date:12/20/2016)... and GENEVA, Dec, 20, 2016   Valencell ... sensor technology, and STMicroelectronics (NYSE: STM), a ... of electronics applications, announced today the launch of ... for biometric wearables that includes ST,s compact ... Valencell,s Benchmark™ biometric sensor system. Together, SensorTile ...
Breaking Biology News(10 mins):